Primer sequences and quantitative determination kit used for simultaneously detecting human CMV and BK virus DNA
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL COLLEGE
- Publication Date
- 2013-01-23
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to biotechnology, is a kind of molecular biology method based on quantitative nucleic acid amplification, particularly relates to using real-time fluorescent quantitative polymerase chain reaction (real-time PCR), by using specific primers to amplify cytomegalovirus (CMV ) and polyomavirus (BKV) conserved fragments, and quantify them by releasing fluorescent signals from specific probes. After optimizing the experimental conditions, a kit that can simultaneously detect CMV DNA and BKV DNA in a single reaction tube was constructed. Background technique
[0002] CMV and BKV are latent viruses in kidney transplant recipients. When immunosuppressive therapy is overdone, both viruses reactivate to varying degrees and damage the transplanted kidney. These viruses can be found in the urine, plasma, and peripheral blood cells of kidney transplant recipients, and have a huge negative impact on the long-term survival of kidney tra...